AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2017

Jun 2, 2017

33090_dirs_2017-06-02_1b4037d7-b967-4c2e-8e75-bbcbfce07cd9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2017-06-01

Reporting Person: Harrell David (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-01	Common Stock	D	500000	$0.78	Disposed	2090750	Direct

Footnotes

F1: The shares were repurchased by the Company pursuant to an agreement dated May 11, 2017, which is attached to the Company's Form 8-K and filed with the SEC on May 17, 2017.